Eco R1 Capital, LLC Logic Bio Therapeutics, Inc. Transaction History

Eco R1 Capital, LLC

  • $2.83 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$4.03 - $7.57 $2.78 Million - $5.21 Million
-688,700 Closed
0 $0
Q1 2021

May 17, 2021
SELL
$6.8 - $9.16 $586,840 - $790,508
-86,300 Reduced 11.14%
688,700 $5.01 Million
Q4 2020

Feb 16, 2021
BUY
$5.29 - $9.1 $4.1 Million - $7.05 Million
775,000 New
775,000 $5.91 Million

About LogicBio Therapeutics, Inc.

LOGC Quotes by TradingView
  • Ticker LOGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,962,700
  • Description
  • LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...
More about LOGC
Track This Portfolio

Track Eco R1 Capital, LLC Portfolio

Follow Eco R1 Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eco R1 Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email